Scholarlink

<p>Significant advancements have been made in the care of the allogeneic hematopoietic stem cell (HCT) recipient. However, they remain one of the most vulnerable groups of patients who may be admitted to the ICU. On the one hand, they have been administered treatment with the goal of achieving cure for their underlying disease, yet their unique immunocompromised trajectory and treatment-associated toxicities continue to challenge the intensivist from a diagnostic and management perspective.&#xa0;While infectious disease, allogeneic HCT and critical care research have improved outcomes, there remain significant areas to advance critical care management to further increase the likelihood of bridging to an acceptable quality of life.&#xa0;This review focuses on care of the critically ill patient undergoing allogeneic HCT for hematologic malignancies, critical care conditions that may arise, contemporary practices in their management, and areas to focus future research.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Contemporary review of critical illness following allogeneic hematopoietic stem cell transplant in adults

  • 期刊论文

  • 发表日期：

    2025年4月16日

查看全文
  • Laveena Munshi,
  • Guillaume Dumas,
  • Bruno Ferreryro,
  • Cristina Gutierrez,
  • Boris Böll,
  • Pedro Castro,
  • Sanjay Chawla,
  • Matteo Di Nardo,
  • Antoine Lafarge,
  • Colleen McEvoy,
  • Djamel Mokart,
  • Antonio Paulo Nassar,
  • Judith Nelson,
  • Frédéric Pène,
  • Peter Schellongowski,
  • Elie Azoulay

摘要

Significant advancements have been made in the care of the allogeneic hematopoietic stem cell (HCT) recipient. However, they remain one of the most vulnerable groups of patients who may be admitted to the ICU. On the one hand, they have been administered treatment with the goal of achieving cure for their underlying disease, yet their unique immunocompromised trajectory and treatment-associated toxicities continue to challenge the intensivist from a diagnostic and management perspective. While infectious disease, allogeneic HCT and critical care research have improved outcomes, there remain significant areas to advance critical care management to further increase the likelihood of bridging to an acceptable quality of life. This review focuses on care of the critically ill patient undergoing allogeneic HCT for hematologic malignancies, critical care conditions that may arise, contemporary practices in their management, and areas to focus future research.